GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Policy Acquisition Expense

Verastem (FRA:2VSA) Policy Acquisition Expense


View and export this data going back to 2012. Start your Free Trial

What is Verastem Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Verastem (FRA:2VSA) Business Description

Industry
Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.